Coronavirus (COVID-19)
Learn more
MSK 21-183:Selective Use of ALND in cT1-2N1 HR+/HER2- Breast Cancer Patients with 1 or 2 Positive Sentinel Lymph Nodes Undergoing Upfront Surgery and Adjuvant Radiation: A Prospective Study
The purpose of this study is to find out how often the researchers can avoid an ALND in women with early-stage, node-positive HR+/HER2- breast cancer who are having upfront surgery. The study researchers think that, if AUS before surgery can help identify people who may have only 1 or 2 affected lymph nodes, it will be possible to perform the less radical standard SLNB during surgery.
Inclusion Criteria
Exclusion Criteria
This study is for patients age 18 Years and older.Available at: Hartford Hospital, Midstate Medical Center and HOCC
Get the latest healthcare news directly in your inbox.
To receive our health news text alerts / text StartHere to 85209